Navigation Links
ULURU Inc. Receives Notice From NYSE Amex Regarding Continued Listing Standards
Date:12/9/2011

ADDISON, Texas, Dec. 9, 2011 /PRNewswire/ -- ULURU Inc. (NYSE AMEX: ULU), a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products, today announced that the Company has received notice from the NYSE Amex (the "Exchange"), dated December 5, 2011, indicating that the Exchange has accepted the Company's plan of compliance and granted the Company an extension until March 21, 2013 to regain compliance with the continued listing standards of Section 1003(a)(iii) of the Exchange's Company Guide.  Previously, the Company had received notice from the Exchange, dated September 21, 2011, that the Company was below the Exchange's stockholders' equity continued listing standards and did not meet the provisions of Section 1003(a)(iii) since the Company reported stockholders' equity of less than $6,000,000 at June 30, 2011 and has incurred losses from continuing operations and/or net losses in its five most recent fiscal years ended December 31, 2010.  The Company will be subject to periodic review by Exchange Staff during the extension period.  Failure to make progress consistent with the plan or to regain compliance with the continued listing standards by the end of the extension period could result in the Company being delisted from the Exchange.

The notice from the Exchange also indicated that the Company is not in compliance with an additional listing standard as set forth in Part 10 of the Exchange's Company Guide.  A review by the Exchange Staff of the Company's Form 10-Q for the period ended September 30, 2011, indicated that the Company does not meet the provisions of Section 1003(a)(iv) since the Company has sustained losses which are so substantial in relation to its overall operations or its existing financial resources, or its financial condition has become so impaired that it appears quest
'/>"/>

SOURCE ULURU Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ULURU Inc. Reports Third Quarter 2011 Financial Results
2. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2011 and to Provide a Business Update
3. ULURU Inc. Announces Altrazeal® Agreement for the European Market
4. ULURU Inc. Receives NYSE Amex Notice of Non-Compliance with Continued Listing Standards
5. ULURU Inc. Enters Into Strategic Financings of Up to $1.6 Million at a Premium to Current Share Price
6. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Second Quarter Ended June 20, 2011 and to Provide a Business Update
7. ULURU Inc. Announces Reverse Stock Split
8. ULURU Inc. Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor
9. ULURU Inc. Announces Voting Results of Reconvened Annual Meeting of Stockholders
10. ULURU Inc. Raises $140,000 in Convertible Debt Offering
11. ULURU Inc. Reports First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 ... My Diabetes Emergency Plan at the 2015 @NatHurricaneCon ... to be prepared to manage your #diabetes before emergencies ... (ACE) – the charitable, educational and scientific arm of ... joined forces with Lilly Diabetes to share the ...
(Date:3/30/2015)... 30, 2015  Check-Cap Ltd. (NASDAQ: CHEK ), ... development of a preparation-free ingestible imaging capsule that utilizes ... today that its CEO, Guy Neev , will ring ... day.  Neev and Check-Cap will participate in the closing ... public offering and simultaneous private placement which raised a ...
(Date:3/30/2015)... and ORANGEBURG, N.Y., March 30, 2015  Uroplasty, ... VSCI ) shareholders have voted at the ... to approve the previously announced agreement and plan ... "We are pleased with the outcome of today,s ... both shareholder groups for approving the merger agreement," ...
Breaking Medicine Technology:Preparation Is Personal for Those with Chronic Illnesses 2Preparation Is Personal for Those with Chronic Illnesses 3Preparation Is Personal for Those with Chronic Illnesses 4Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4
... , EAST HANOVER, N.J., Oct. 12 Novartis Pharma AG ... rights to Fanapt(TM) (iloperidone), a new oral medication ... (FDA) for the acute treatment of adults with schizophrenia. Novartis ... early 2010. , As part of the agreement with ...
... 12 Hospira, Inc. (NYSE: HSP ), a leading ... the company will present at the Credit Suisse 18th Annual ... , The presentation is scheduled to begin at 8:00 a.m. ... will be available to all interested parties through a live ...
Cached Medicine Technology:Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 2Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 3Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 4Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 5Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 6Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 7Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia 8
(Date:3/31/2015)... CA (PRWEB) March 31, 2015 Dr. Poneh ... now offer patients valuable savings through new Spring specials. Dr. ... off the holiday celebration this year by taking advantage of ... , "Spring brings together friends and loved ones that ... media. We are pleased to offer solutions for a great ...
(Date:3/31/2015)... 31, 2015 A' Design Award and ... Bruker EVOQ by Daniel Dion has been announced as ... Scientific Instruments, Medical Devices and Research Equipment Design ... the creative mind behind the award winning Medical Product ... developed under the direction of Dr. Rohan Thakur and ...
(Date:3/31/2015)... 2015 According to a recent YouGov/Huffington ... Americans interviewed supported detox and abstinence, while only 19% ... methadone.(1) Although many within the healthcare community advocate for ... suggest that most Americans concur with Novus Medical ... drug use is a better approach than prescribing other ...
(Date:3/31/2015)... March 31, 2015 A team of ... polyphenol with anti-cancer properties, into mesothelioma cancer cells. Surviving ... research on its website. Click here to read ... the yellow color to the spice turmeric, has limited ... bioavailability. Biomaterials experts at Università di Napoli Federico II ...
(Date:3/31/2015)... TN (PRWEB) March 31, 2015 Dr. ... welcomes warmer temperatures and sunshine; however, it's important to be ... eye damage. Experts say more than 90 percent ... few precautions and wearing safety glasses. Dr. Shofner shares five ... this season. , 1) Yard Work. While using a lawn ...
Breaking Medicine News(10 mins):Health News:West Hollywood Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering Various Special Offers Just in Time for Spring 2Health News:Daniel Dion wins Golden in A' Medical Product Design Awards 2Health News:Novus Medical Detox Center Highlights Survey Findings: More Americans Support Detox and Rehab Over Methadone as Treatment for Heroin Addiction 2Health News:Novus Medical Detox Center Highlights Survey Findings: More Americans Support Detox and Rehab Over Methadone as Treatment for Heroin Addiction 3Health News:Novus Medical Detox Center Highlights Survey Findings: More Americans Support Detox and Rehab Over Methadone as Treatment for Heroin Addiction 4Health News:New Research Reveals Novel Delivery Method for Potential Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 2Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 3Health News:Popular Springtime Activities That Could Cause Irreversible Eye Damage by Renowned Eye Surgeon Dr. Stewart Shofner 4
... cholesterol and high blood pressure in people who,ve had a ... attack, according to a study to be presented as part ... Neurology,s 61st Annual Meeting in Seattle, April 25 - May ... LDL cholesterol, low HDL cholesterol, high triglycerides, and high blood ...
... -- Traumatic brain injury (TBI), a complex ... among Veterans and has been called one of the ... TBI is wide-ranging. Among its goals: shedding light on ... screening and diagnosis; developing drugs to treat brain injury ...
... April 30, 2009) A unique mother-daughter study that ... shows that percent of breast water could be linked to ... , The findings, published online today in Lancet Oncology ... more about breast density, an inheritable characteristic known to be ...
... of a novel therapy that uses magnetic pulses to ... a promising alternative to medication. , The therapy is ... were presented today (April 29, 2009) during the annual ... , In a previous randomized controlled clinical study ...
... Washing Hands, Recognizing Symptoms Key to Prevent Spread , ... attention to symptoms of illness are just some of ... the risk from the swine flu (H1N1) outbreak, the ... )"This is a serious situation that has ...
... ... 9:00 a.m. EDT, ... 1-800-814-4860, ... invites analysts and investors to participate in a briefing on Wednesday, May 6, 2009, with ...
Cached Medicine News:Health News:Controlling Cholesterol, Blood Pressure Adds Up to Prevent Stroke 2Health News:Video: Turning Hope Into Reality - Traumatic Brain Injury Research at the VA 2Health News:Mother-daughter breast density study points way to earlier cancer risk assessment 2Health News:New therapy based on magnetic stimulation shows promise for non-drug treatment for migraine 2Health News:Red Cross Urges Families and Communities to Prepare During Swine Flu Outbreak 2Health News:Red Cross Urges Families and Communities to Prepare During Swine Flu Outbreak 3Health News:Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 First Quarter Results 2
... most powerful, comprehensive and most proven ... OfficeMate is the most widely used ... out of every three computerized eyecare ... of all your practice management needs ...
... management software for eyecare professionals- ... multi-tasking, multi-office practice management system, ... technology- Winx Pro is a ... you in effectively managing the ...
Easy-to-use and afforable practice management software. For more details, please contact First Insight....
... Working with over 2,500 ... proud to serve one ... client bases in the ... PM Ophthalmology, we are ...
Medicine Products: